We Analyzed the Future Direction of Brooklyn ImmunoTherapeutics Inc. (BTX), Here is What We Found – News Heater
Home  »  Trending   »  We Analyzed the Future Direction of Brooklyn Immun...

We Analyzed the Future Direction of Brooklyn ImmunoTherapeutics Inc. (BTX), Here is What We Found

Brooklyn ImmunoTherapeutics Inc. (NASDAQ:BTX) went up by 14.19% from its latest closing price compared to the recent 1-year high of $23.34. The company’s stock price has collected 10.06% of gains in the last five trading sessions.

Is It Worth Investing in Brooklyn ImmunoTherapeutics Inc. (NASDAQ :BTX) Right Now?

Plus, the 36-month beta value for BTX is at 4.77. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for Brooklyn ImmunoTherapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $3.50, which is $3.9 above the current price. BTX currently public float of 32.55M and currently shorts hold a 10.63% ratio of that float. Today, the average trading volume of BTX was 562.49K shares.

BTX’s Market Performance

BTX stocks went up by 10.06% for the week, with a monthly drop of -16.17% and a quarterly performance of -71.99%, while its annual performance rate touched -96.72%. The volatility ratio for the week stands at 13.11% while the volatility levels for the past 30 days are set at 12.38% for Brooklyn ImmunoTherapeutics Inc. The simple moving average for the period of the last 20 days is 0.21% for BTX stocks with a simple moving average of -86.25% for the last 200 days.

Analysts’ Opinion of BTX

Many brokerage firms have already submitted their reports for BTX stocks, with Cantor Fitzgerald repeating the rating for BTX by listing it as a “Overweight.” The predicted price for BTX in the upcoming period, according to Cantor Fitzgerald is $9 based on the research report published on December 29th of the previous year 2021.

Maxim Group, on the other hand, stated in their research note that they expect to see BTX reach a price target of $20. The rating they have provided for BTX stocks is “Buy” according to the report published on October 06th, 2021.

BTX Trading at -32.78% from the 50-Day Moving Average

After a stumble in the market that brought BTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.43% of loss for the given period.

Volatility was left at 12.38%, however, over the last 30 days, the volatility rate increased by 13.11%, as shares sank -9.20% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -64.11% lower at present.

During the last 5 trading sessions, BTX rose by +10.06%, which changed the moving average for the period of 200-days by -94.93% in comparison to the 20-day moving average, which settled at $0.5951. In addition, Brooklyn ImmunoTherapeutics Inc. saw -85.63% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at BTX starting from DENNY GEORGE P III, who purchase 1 shares at the price of $11.99 back on Jul 14. After this action, DENNY GEORGE P III now owns 3 shares of Brooklyn ImmunoTherapeutics Inc., valued at $12 using the latest closing price.

DENNY GEORGE P III, the 10% Owner of Brooklyn ImmunoTherapeutics Inc., purchase 1 shares at $14.11 during a trade that took place back on Jul 09, which means that DENNY GEORGE P III is holding 2 shares at $14 based on the most recent closing price.

Stock Fundamentals for BTX

Equity return is now at value -972.70, with -311.20 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 5.10.